NCT06615674 - Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 21, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 7, 2024

Conditions

Acute Myocardial Infarction (AMI)STEMI - ST Elevation Myocardial Infarction (MI)NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

Interventions

DRUG

Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia

The first group is the Dapagliflozin group, which will get Dapagliflozin 10mg once a day every morning for 14 days. And the second group will have placebo for 14 days.

Trial Locations (1)

57126

Dr. Moewardi General Hospital, Jebres, Surakarta, Central of Java, 57126, Surakarta

All Listed Sponsors

lead

Yoga Yudhistira

OTHER